The University of Chicago Header Logo

Connection

Adil Javed to Rituximab

Back to Details
This is a "connection" page, showing publications Adil Javed has written about Rituximab.
Adil Javed
Connection Strength
0.448
Rituximab
  1. Effectiveness of rituximab versus oral immunosuppressive therapies in neuromyelitis optica spectrum disorder in a racially diverse cohort of subjects: A single-center retrospective study. Mult Scler Relat Disord. 2023 Jun; 74:104718.
    View in: PubMed
    Score: 0.212
  2. Long-term safety of rituximab induced peripheral B-cell depletion in autoimmune neurological diseases. PLoS One. 2018; 13(1):e0190425.
    View in: PubMed
    Score: 0.147
  3. Efficacy and safety of rituximab in pediatric neuromyelitis optica. J Child Neurol. 2011 Feb; 26(2):244-7.
    View in: PubMed
    Score: 0.090
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.